"Peptichemio" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A mixture of six synthetic oligopeptides, each containing MELPHALAN. It is used as a broad-spectrum antineoplastic due to its alkylating and antimetabolic actions but, is toxic to bone marrow, gastrointestinal system and vasculature.
| Descriptor ID |
D010440
|
| MeSH Number(s) |
D02.455.526.728.650.594.690 D12.644.456.726
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Peptichemio".
Below are MeSH descriptors whose meaning is more specific than "Peptichemio".
This graph shows the total number of publications written about "Peptichemio" by people in this website by year, and whether "Peptichemio" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Peptichemio" by people in Profiles.
-
Esophageal complications from combined chemoradiotherapy (cyclophosphamide + Adriamycin + cisplatin + XRT) in the treatment of non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 1985 Mar; 11(3):511-9.
-
Combination chemotherapy of metastatic breast carcinoma with cyclophosphamide, adriamycin, and peptichemio. Cancer. 1984 May 01; 53(9):1836-40.
-
Combination chemotherapy with continuous infusion vinblastine and peptichemio for patients with advanced metastatic breast cancer. Am J Clin Oncol. 1982 Oct; 5(5):511-4.
-
AMSA and peptichemio in the treatment of advances metastatic breast cancer: a phase II study. Am J Clin Oncol. 1982 Aug; 5(4):383-7.
-
Peptichemio versus melphalan (L-PAM) in advanced breast cancer. Cancer. 1982 May 01; 49(9):1767-70.
-
A phase II study of peptichemio in advanced breast cancer. Cancer. 1980 May 15; 45(10):2524-8.